465624592	465624592	CD	B-NP	O
|	|	NN	I-NP	O
OHMC	OHMC	NN	I-NP	O
|	|	NN	I-NP	O
41767657	41767657	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4941442	4941442	CD	B-NP	O
|	|	CC	I-NP	O
1/21/2006	1/21/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHF	CHF	NNP	I-NP	I-protein
EXACERBATION	EXACERBATION	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/26/2006	3/26/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/14/2006	7/14/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
DEMARTINO	DEMARTINO	NN	B-NP	O
,	,	,	O	O
HARRIS	HARRIS	NNP	B-NP	O
MD	MD	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
To	To	TO	B-PP	O
Rehabilitation	Rehabilitation	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Enteric-coated	Enteric-coated	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
amiodarone	amiodarone	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	O
NPH	NPH	NN	I-NP	O
7	7	CD	B-NP	O
units	unit	NNS	I-NP	O
q.a.m.	q.a.m.	NN	B-NP	O
and	and	CC	O	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	RB	B-ADVP	O
subcutaneously	subcutaneously	RB	I-ADVP	O
,	,	,	O	O
Atrovent	Atrovent	NNP	B-NP	O
HFA	HFA	NNP	I-NP	O
inhaler	inhaler	NN	I-NP	O
2	2	CD	B-NP	O
puffs	puff	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
q.i.d.	q.i.d.	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
wheezing	wheezing	NN	B-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
gluconate	gluconate	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	O
5-10	5-10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
pain	pain	NN	B-NP	O
,	,	,	O	O
senna	senna	NN	B-NP	O
tablets	tablet	NNS	I-NP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
spironolactone	spironolactone	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-PP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
therapeutic	therapeutic	JJ	B-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
torsemide	torsemide	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
OxyContin	OxyContin	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Cozaar	Cozaar	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Remeron	Remeron	NNP	B-NP	O
7.5	7.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
aspartate	aspartate	NN	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Discharge	Discharge	NN	B-NP	O
diet	diet	NN	I-NP	O
is	be	VBZ	B-VP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
fluid	fluid	NN	I-NP	O
restrict	restrict	NN	I-NP	O
.	.	.	O	O

Liberal	Liberal	JJ	B-NP	O
house	house	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Foot	Foot	NN	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Decompensated	Decompensate	VBN	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
bilateral	bilateral	JJ	I-NP	O
knee	knee	NN	I-NP	O
amputation	amputation	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
BKA	BKA	NN	I-NP	O
.	.	.	O	O

RETURN	RETURN	NN	B-NP	O
TO	TO	NN	I-NP	O
WORK	WORK	NN	I-NP	O
:	:	:	O	O
Not	Not	RB	B-ADJP	O
applicable	applicable	JJ	I-ADJP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	JJ	B-NP	O
APPOINTMENTS	APPOINTMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Ricardo	Ricardo	NNP	I-NP	O
Dzierzanowski	Dzierzanowski	NNP	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
Pipe	Pipe	NNP	B-NP	O
Shanm	Shanm	NNP	I-NP	O
Hasb	Hasb	NNP	I-NP	O
Nota	Nota	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
within	within	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Edwin	Edwin	NNP	I-NP	O
Mellor	Mellor	NNP	I-NP	O
within	within	IN	B-PP	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
.	.	.	O	O

OPERATIONS	OPERATIONS	NNS	B-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
TREATMENTS	TREATMENTS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
Shortness	Shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
73-year-old	73-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
,	,	,	O	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
valvular	valvular	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
known	know	VBN	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
15-20	15-20	CD	B-NP	O
%	%	NN	I-NP	O
as	as	IN	B-PP	O
of	of	IN	B-PP	O
9/19	9/19	CD	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Rose-le	Rose-le	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
from	from	IN	B-PP	O
No	No	NNP	B-NP	O
Memorial	Memorial	NNP	I-NP	O
with	with	IN	B-PP	O
signs	sign	NNS	B-NP	O
and	and	CC	I-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
decompensated	decompensate	VBN	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
acute	acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
8/7/06	8/7/06	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
left	left	JJ	I-NP	O
foot	foot	NN	I-NP	O
toe	toe	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
nonhealing	nonhealing	JJ	B-ADJP	O
.	.	.	O	O

Multiple	Multiple	JJ	B-NP	O
surgeries	surgery	NNS	I-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
with	with	IN	B-PP	O
persistent	persistent	JJ	B-NP	O
nonhealing	nonhealing	JJ	I-NP	O
wounds	wound	NNS	I-NP	O
:	:	:	O	O
Left	Left	JJ	B-NP	O
great	great	JJ	I-NP	O
toe	toe	NN	I-NP	O
amputation	amputation	NN	I-NP	O
on	on	IN	B-PP	O
2/18/06	2/18/06	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
heal	heal	VB	I-VP	O
despite	despite	IN	B-PP	O
SFA	SFA	NNP	B-NP	O
to	to	TO	B-PP	O
perineal	perineal	JJ	B-NP	O
artery	artery	NN	I-NP	O
bypassing	bypass	VBG	B-VP	O
the	the	DT	B-NP	O
composite	composite	JJ	I-NP	O
vein	vein	NN	I-NP	O
.	.	.	O	O

Had	Have	VBD	B-VP	O
a	a	DT	B-NP	O
short	short	JJ	I-NP	O
CICU	CICU	NN	I-NP	O
stay	stay	NN	I-NP	O
for	for	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
postoperatively	postoperatively	RB	B-ADVP	O
,	,	,	O	O
maintained	maintain	VBN	B-VP	O
on	on	IN	B-PP	O
dobutamine	dobutamine	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
7/25/06	7/25/06	CD	B-NP	O
underwent	undergo	VBD	B-VP	O
debridement	debridement	NN	B-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
medial	medial	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/7/06	10/7/06	CD	B-NP	O
transmetatarsal	transmetatarsal	JJ	I-NP	O
amputation	amputation	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
11/22/06	11/22/06	CD	B-NP	O
,	,	,	O	O
debridement	debridement	NN	B-NP	O
of	of	IN	B-PP	O
transmetatarsal	transmetatarsal	JJ	B-NP	O
amputation	amputation	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
9/22/06	9/22/06	CD	B-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	NN	I-NP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
knee	knee	NN	I-NP	O
amputation	amputation	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
normal	normal	JJ	B-ADJP	O
prior	prior	JJ	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
final	final	JJ	I-NP	O
surgery	surgery	NN	I-NP	O
until	until	IN	B-PP	O
5/29/06	5/29/06	CD	B-NP	O
to	to	TO	B-PP	O
8/13/06	8/13/06	CD	B-NP	O
when	when	WRB	B-ADVP	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
rose	rise	VBD	B-VP	O
from	from	IN	B-PP	O
1.3	1.3	CD	B-NP	O
to	to	TO	B-PP	O
2.2	2.2	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
acute	acute	JJ	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
there	there	RB	I-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
this	this	DT	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
prerenal	prerenal	JJ	B-NP	O
azotemia	azotemia	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
changed	change	VBN	I-VP	O
much	much	RB	B-ADVP	O
from	from	IN	B-PP	O
2.2	2.2	CD	B-NP	O
to	to	TO	B-PP	O
2.5	2.5	CD	B-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

Diuretics	Diuretic	NNS	B-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
at	at	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
facility	facility	NN	I-NP	O
until	until	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
increased	increase	VBN	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
except	except	IN	B-PP	O
occasional	occasional	JJ	B-NP	O
lightheadedness	lightheadedness	NN	I-NP	O
,	,	,	O	O
depressed	depressed	JJ	B-NP	O
mood	mood	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
lack	lack	NN	B-NP	O
of	of	IN	B-PP	O
motivation	motivation	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
,	,	,	O	O
uses	use	VBZ	B-VP	O
1	1	CD	B-NP	O
pillow	pillow	NN	I-NP	O
regularly	regularly	RB	B-ADVP	O
,	,	,	O	O
denies	deny	VBZ	B-VP	O
paroxysmal	paroxysmal	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
denies	deny	VBZ	B-VP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
very	very	RB	B-NP	O
limited	limited	JJ	I-NP	O
movement	movement	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
GERD	GERD	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
status	status	NN	I-NP	I-protein
post	post	NN	I-NP	I-protein
MI	MI	NN	I-NP	I-protein
in	in	IN	B-PP	O
1996	1996	CD	B-NP	O
,	,	,	O	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
CABG	CABG	NN	I-NP	B-protein
in	in	IN	B-PP	O
5/12	5/12	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
LIMA	LIMA	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
,	,	,	O	O
SVG	SVG	NN	B-NP	O
to	to	TO	B-PP	O
PDA	PDA	NN	B-NP	B-protein
,	,	,	O	O
SVG	SVG	NN	B-NP	O
to	to	TO	B-PP	O
OM1	OM1	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
mitral	mitral	JJ	B-NP	O
valve	valve	NN	I-NP	O
annuloplasty	annuloplasty	NN	I-NP	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
,	,	,	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
bilateral	bilateral	JJ	B-ADJP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
knee	knee	NN	I-NP	O
amputation	amputation	NN	I-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
from	from	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
related	related	JJ	I-NP	O
foot	foot	NN	I-NP	O
ulcers	ulcer	NNS	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	O	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
sick	sick	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
second-degree	second-degree	JJ	B-NP	O
heart	heart	NN	I-NP	O
block	block	NN	I-NP	O
,	,	,	O	O
AICD	AICD	NNP	B-NP	O
placed	place	VBD	B-VP	O
10/27	10/27	CD	B-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
hematoma	hematoma	NN	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
admissions	admission	NNS	B-NP	O
for	for	IN	B-PP	O
hyponatremia	hyponatremia	NN	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
SFA	SFA	NN	B-NP	B-protein
to	to	TO	B-PP	O
perineal	perineal	JJ	B-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
to	to	TO	B-PP	O
incompetent	incompetent	JJ	B-NP	O
pain	pain	NN	I-NP	O
in	in	IN	B-PP	O
10/14	10/14	CD	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Amiodarone	Amiodarone	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

Atrovent	Atrovent	VB	B-VP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
puffs	puff	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
q.i.d.	q.i.d.	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
wheezing	wheezing	NN	B-NP	O
,	,	,	O	O
Celexa	Celexa	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Diovan	Diovan	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	I-NP	O
enteric-coated	enteric-coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
25	25	CD	B-NP	O
units	unit	NNS	I-NP	O
every	every	DT	B-NP	O
day	day	NN	I-NP	O
subcutaneous	subcutaneous	JJ	B-ADJP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
160	160	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Lipitor	Lipitor	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
therapeutic	therapeutic	JJ	B-NP	O
multivitamin	multivitamin	NN	I-NP	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
solsite	solsite	NN	B-NP	O
topical	topical	JJ	I-NP	O
.	.	.	O	O

IMPRESSION	IMPRESSION	NN	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
73-year-old	73-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
and	and	CC	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
decompensated	decompensate	VBN	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
diuretics	diuretic	NNS	I-NP	O
being	be	VBG	B-VP	O
held	hold	VBN	I-VP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Review	Review	NN	B-NP	O
of	of	IN	B-PP	O
chart	chart	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
showed	show	VBD	B-VP	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
is	be	VBZ	B-VP	O
actually	actually	RB	B-ADJP	O
present	present	JJ	I-ADJP	O
since	since	IN	B-SBAR	O
the	the	DT	B-NP	O
perioperative	perioperative	JJ	I-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
BKA	BKA	NN	I-NP	B-protein
.	.	.	O	O

After	After	IN	B-PP	O
being	be	VBG	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cardiology	cardiology	NN	I-NP	O
service	service	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
successfully	successfully	RB	B-ADVP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
venous	venous	JJ	B-NP	O
congestion	congestion	NN	I-NP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
active	active	JJ	I-NP	O
issues	issue	NNS	I-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
include	include	VBP	B-VP	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
acute	acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEMS	SYSTEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
Ischemia	Ischemia	NNP	B-NP	O
:	:	:	O	O
Known	Known	NNP	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
x3	x3	NN	I-NP	O
,	,	,	O	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
troponin	troponin	NN	B-NP	O
elevation	elevation	NN	I-NP	O
likely	likely	RB	B-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-VP	O
demand	demand	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
for	for	IN	B-PP	O
having	have	VBG	B-VP	O
his	his	PRP$	B-NP	O
diuretics	diuretic	NNS	I-NP	O
held	hold	VBD	B-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
trend	trend	VB	I-VP	O
down	down	RP	B-PRT	O
post-diuresis	post-diuresis	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
continued	continue	VBD	B-VP	O
aspirin	aspirin	NN	B-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
held	hold	VBD	B-VP	O
his	his	PRP$	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
given	give	VBN	B-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
cough	cough	NN	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
ARF	ARF	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
ultimately	ultimately	RB	B-VP	O
restarted	restart	VBD	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
ARB	ARB	NN	B-NP	B-protein
,	,	,	O	O
after	after	IN	B-PP	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
had	have	VBD	B-VP	O
normalized	normalize	VBN	I-VP	O
.	.	.	O	O

Statins	Statin	NNS	B-NP	B-protein
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
held	hold	VBN	I-VP	O
until	until	IN	B-SBAR	O
we	we	PRP	B-NP	O
were	be	VBD	B-VP	O
certain	certain	JJ	B-ADJP	O
his	his	PRP$	B-NP	O
liver	liver	NN	I-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
decreasing	decrease	VBG	I-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
pump	pump	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
floor	floor	NN	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
on	on	IN	B-PP	O
presentation	presentation	NN	B-NP	O
,	,	,	O	O
maintained	maintain	VBN	B-VP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
grams	gram	NNS	I-NP	O
salt	salt	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
fluid	fluid	NN	I-NP	O
restriction	restriction	NN	I-NP	O
diet	diet	NN	I-NP	O
with	with	IN	B-PP	O
1-2	1-2	CD	B-NP	O
liters	liter	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
goal	goal	NN	I-NP	O
diuresis	diuresis	NN	I-NP	O
attained	attain	VBN	B-VP	O
by	by	IN	B-PP	O
using	use	VBG	B-VP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
torsemide	torsemide	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
30	30	CD	B-NP	O
minutes	minute	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
each	each	DT	B-NP	O
torsemide	torsemide	NN	I-NP	O
dose	dose	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
average	average	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
liter	liter	NN	I-NP	O
fluid	fluid	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Diuresis	Diuresis	NN	B-NP	O
was	be	VBD	B-VP	O
affected	affect	VBN	I-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
status	status	NN	I-NP	O
gradually	gradually	RB	B-VP	O
improved	improve	VBN	I-VP	O
.	.	.	O	O

Spironolactone	Spironolactone	NN	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
held	hold	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
high	high	JJ	B-NP	O
K	K	NN	I-NP	O
but	but	CC	O	O
was	be	VBD	B-VP	O
re-added	re-adde	VBN	I-VP	O
on	on	IN	B-PP	O
7/20/06	7/20/06	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
distention	distention	NN	I-NP	O
dropped	drop	VBD	B-VP	O
from	from	IN	B-PP	O
initial	initial	JJ	B-NP	O
presentation	presentation	NN	I-NP	O
above	above	IN	B-PP	O
the	the	DT	B-NP	O
earlobes	earlobe	NNS	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
30-degree	30-degree	JJ	I-NP	O
angle	angle	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
JVP	JVP	NN	I-NP	B-protein
of	of	IN	B-PP	O
6-7	6-7	CD	B-NP	O
cm	cm	NN	I-NP	O
at	at	IN	B-PP	O
30	30	CD	B-NP	O
degree	degree	NN	I-NP	O
angle	angle	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
rise	rise	VB	I-VP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
prerenal	prerenal	JJ	B-NP	O
azotemia	azotemia	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
over	over	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
and	and	CC	O	O
when	when	WRB	B-ADVP	O
his	his	PRP$	B-NP	O
torsemide	torsemide	NN	I-NP	O
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
to	to	TO	B-PP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	O
was	be	VBD	B-VP	O
dropped	drop	VBN	I-VP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
regimen	regimen	NN	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
drop	drop	VB	I-VP	O
again	again	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
even	even	RB	B-NP	O
Ins	In	NNS	I-NP	B-protein
and	and	CC	I-NP	O
Outs	Out	NNS	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
rhythm	rhythm	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
is	be	VBZ	B-VP	O
ventricularly	ventricularly	RB	I-VP	O
paced	pace	VBN	I-VP	O
on	on	IN	B-PP	O
symmetry	symmetry	NN	B-NP	O
for	for	IN	B-PP	O
duration	duration	NN	B-NP	O
of	of	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NNP	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
initial	initial	JJ	B-NP	O
O2	O2	NN	I-NP	O
dependence	dependence	NN	I-NP	O
.	.	.	O	O

Continued	Continue	VBN	B-VP	O
inhaled	inhale	VBD	B-VP	O
ipratropium	ipratropium	NN	B-NP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
medication	medication	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
achieve	achieve	VB	I-VP	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Initial	Initial	JJ	B-NP	O
acute	acute	JJ	I-NP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
thought	think	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
and	and	CC	O	O
forward	forward	JJ	B-NP	O
flow	flow	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
decompensated	decompensate	VBN	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
improved	improve	VBD	B-VP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
heart	heart	NN	I-NP	O
likely	likely	RB	B-ADVP	O
moved	move	VBD	B-VP	O
to	to	TO	B-PP	O
more	more	RBR	B-NP	O
useful	useful	JJ	I-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
starling	starling	NN	I-NP	O
curve	curve	NN	I-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
hydronephrosis	hydronephrosis	NN	B-NP	O
as	as	IN	B-SBAR	O
was	be	VBD	B-VP	O
test	test	NN	B-NP	O
for	for	IN	B-PP	O
urine	urine	NN	B-NP	B-cell_type
eosinophils	eosinophil	NNS	I-NP	I-cell_type
.	.	.	O	O

Hyponatremia	Hyponatremia	NN	B-NP	O
was	be	VBD	B-VP	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
improved	improve	VBN	B-VP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
maintained	maintain	VBN	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
2-3	2-3	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
achieve	achieve	VB	I-VP	O
this	this	DT	B-NP	O
goal	goal	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
Coumadin	Coumadin	NNP	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
adjusted	adjust	VBN	I-VP	O
to	to	TO	B-PP	O
mg	mg	NN	B-NP	O
p.o.	p.o.	FW	I-NP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
chemo	chemo	NN	B-NP	O
and	and	CC	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
service	service	NN	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
with	with	IN	B-PP	O
weekly	weekly	JJ	B-NP	O
tests	test	NNS	I-NP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
sure	sure	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
maintained	maintain	VBN	I-VP	O
within	within	IN	B-PP	O
this	this	DT	B-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
insulin-dependent	insulin-dependent	JJ	B-ADJP	O
,	,	,	O	O
covered	cover	VBN	B-VP	O
on	on	IN	B-PP	O
NPH	NPH	NN	B-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
q.p.m.	q.p.m.	NN	B-NP	O
with	with	IN	B-PP	O
aspartate	aspartate	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
for	for	IN	B-PP	O
duration	duration	NN	B-NP	O
of	of	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Psych	Psych	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
Celexa	Celexa	NN	B-NP	O
per	per	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
for	for	IN	B-PP	O
likely	likely	JJ	B-NP	O
depressive	depressive	JJ	I-NP	O
mood	mood	NN	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
recent	recent	JJ	B-NP	O
bilateral	bilateral	JJ	I-NP	O
knee	knee	NN	I-NP	O
amputation	amputation	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
what	what	WP	B-NP	O
is	be	VBZ	B-VP	O
quite	quite	RB	B-ADJP	O
possible	possible	JJ	I-ADJP	O
that	that	IN	B-SBAR	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
depression	depression	NN	I-NP	O
precedes	precede	VBZ	B-VP	O
the	the	DT	B-NP	O
bilateral	bilateral	JJ	I-NP	O
knee	knee	NN	I-NP	O
amputation	amputation	NN	I-NP	O
and	and	CC	O	O
informs	inform	NNS	B-NP	O
much	much	JJ	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
overall	overall	JJ	I-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
PCP	PCP	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Micheal	Micheal	NNP	I-NP	O
L	L	NNP	I-NP	O
Davirro	Davirro	NNP	I-NP	O
,	,	,	O	O
aware	aware	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
situation	situation	NN	I-NP	O
and	and	CC	I-NP	O
managing	managing	NN	I-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
inpatient	inpatient	NN	I-NP	O
psychiatry	psychiatry	NN	I-NP	O
consultation	consultation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
Remeron	Remeron	NNP	B-NP	O
7.5	7.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
of	of	IN	B-PP	O
Celexa	Celexa	NNP	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
medication	medication	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	IN	B-PP	O
one	one	CD	B-NP	O
fall	fall	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
bed	bed	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

Head	Head	JJ	B-NP	O
CT	CT	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
bleed	bleed	NN	B-NP	O
or	or	CC	I-NP	O
trauma	trauma	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
head	head	NN	I-NP	O
to	to	TO	B-PP	O
head	head	NN	B-NP	O
.	.	.	O	O

Examination	Examination	NN	B-NP	O
of	of	IN	B-PP	O
back	back	NN	B-NP	O
and	and	CC	I-NP	O
extremities	extremity	NNS	I-NP	O
reveals	reveal	VBZ	B-VP	O
no	no	DT	B-NP	O
focal	focal	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
or	or	CC	I-NP	O
ecchymoses	ecchymosis	NNS	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
initially	initially	RB	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
with	with	IN	B-PP	O
uncomplicated	uncomplicated	JJ	B-NP	O
course	course	NN	I-NP	O
with	with	IN	B-PP	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Wound	Wound	NN	B-NP	O
:	:	:	O	O
Wound	Wound	JJ	B-NP	O
care	care	NN	I-NP	O
nurse	nurse	NN	I-NP	O
consulted	consult	VBN	B-VP	O
for	for	IN	B-PP	O
BKA	BKA	NN	B-NP	O
wound	wound	NN	I-NP	O
and	and	CC	O	O
small	small	JJ	B-NP	O
decubitus	decubitus	NN	I-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
back	back	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
DuoDERM	DuoDERM	NN	B-NP	O
,	,	,	O	O
BKA	BKA	NN	B-NP	B-DNA
site	site	NN	I-NP	I-DNA
healing	heal	VBG	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Fluids	Fluid	NNS	B-NP	O
,	,	,	I-NP	O
electrolytes	electrolyte	NNS	I-NP	O
and	and	CC	I-NP	O
nutrition	nutrition	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
on	on	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
,	,	,	I-NP	O
2000	2000	CD	I-NP	O
calorie	calorie	NN	I-NP	O
diabetic	diabetic	JJ	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
it	it	PRP	B-NP	O
became	become	VBD	B-VP	O
apparent	apparent	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
severely	severely	RB	I-VP	O
malnourished	malnourishe	VBN	I-VP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
diet	diet	NN	I-NP	O
was	be	VBD	B-VP	O
liberalized	liberalize	VBN	I-VP	O
to	to	TO	B-VP	O
allow	allow	VB	I-VP	O
for	for	IN	B-PP	O
nutritional	nutritional	JJ	B-NP	O
supplementation	supplementation	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

PPX	PPX	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
maintained	maintain	VBN	B-VP	O
on	on	IN	B-PP	O
subcutaneous	subcutaneous	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
and	and	CC	I-NP	O
Nexium	Nexium	NN	I-NP	O
as	as	IN	B-PP	O
DVT	DVT	NN	B-NP	O
and	and	CC	I-NP	O
GI	GI	NN	I-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Code	Code	NNP	B-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

TO	TO	TO	B-PP	O
DO	DO	NN	B-NP	B-protein
PLAN	PLAN	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

Discharge	Discharge	VB	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
rehab	rehab	VB	I-VP	O
on	on	IN	B-PP	O
current	current	JJ	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
working	work	VBG	I-VP	O
with	with	IN	B-PP	O
PT	PT	NN	B-NP	O
and	and	CC	I-NP	O
OT	OT	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
appears	appear	VBZ	B-VP	O
well	well	RB	I-VP	O
positioned	position	VBN	I-VP	O
to	to	TO	I-VP	O
take	take	VB	I-VP	O
advantage	advantage	NN	B-NP	O
of	of	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
facilities	facility	NNS	I-NP	O
services	service	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Maintain	Maintain	NNP	B-NP	O
new	new	JJ	I-NP	O
prescription	prescription	NN	I-NP	O
of	of	IN	B-PP	O
Remeron	Remeron	NNP	B-NP	O
,	,	,	O	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
psychiatry	psychiatry	NN	B-NP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
depressive	depressive	JJ	B-NP	O
disorder/adjustment	disorder/adjustment	NN	I-NP	O
disorder	disorder	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
off	off	RP	B-PRT	O
beta-blocker	beta-blocker	NN	B-NP	O
.	.	.	O	O

PCP	PCP	NN	B-NP	O
may	may	MD	B-VP	O
choose	choose	VB	I-VP	O
to	to	TO	I-VP	O
start	start	VB	I-VP	O
beta-blocker	beta-blocker	NN	B-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
low-dose	low-dose	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
setting	setting	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Fasciculations	Fasciculation	NNS	B-NP	O
noted	note	VBN	B-VP	O
during	during	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
fine	fine	JJ	I-NP	O
fasciculations	fasciculation	NNS	I-NP	O
at	at	IN	B-PP	O
hands	hand	NNS	B-NP	O
in	in	IN	B-PP	O
Surga	Surga	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

Maybe	Maybe	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
malnutrition	malnutrition	NN	B-NP	O
and	and	CC	I-NP	O
diaries	diary	NNS	I-NP	O
is	be	VBZ	B-VP	O
,	,	,	O	O
but	but	CC	O	O
may	may	MD	B-VP	O
merit	merit	VB	I-VP	O
further	further	JJ	B-NP	O
workup	workup	NN	I-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
context	context	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
rising	rise	VBG	I-VP	O
alkaline	alkaline	NN	B-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
during	during	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
,	,	,	O	O
CT	CT	NN	B-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
incidentally	incidentally	RB	B-ADVP	O
showed	show	VBD	B-VP	O
gallstone	gallstone	NN	B-NP	O
present	present	JJ	B-ADJP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
gallbladder	gallbladder	NN	I-NP	O
,	,	,	O	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
LFTs	LFT	NNS	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
context	context	NN	I-NP	O
and	and	CC	O	O
possible	possible	JJ	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
may	may	MD	B-VP	O
merit	merit	VB	I-VP	O
consideration	consideration	NN	B-NP	O
and	and	CC	O	O
further	further	JJ	B-NP	O
outpatient	outpatient	NN	I-NP	O
workup	workup	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	B-protein
clinic	clinic	JJ	I-NP	I-protein
given	give	VBN	I-NP	I-protein
goal	goal	NN	I-NP	I-protein
INR	INR	NN	I-NP	I-protein
of	of	IN	B-PP	O
2.0-3	2.0-3	CD	B-NP	O
.0	.0	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
and	and	CC	I-NP	O
BUN	BUN	NN	I-NP	B-protein
should	should	MD	B-VP	O
be	be	VB	I-VP	O
checked	check	VBN	I-VP	O
along	along	IN	B-ADVP	O
with	with	IN	B-PP	O
electrolytes	electrolyte	NNS	B-NP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
sure	sure	JJ	B-ADJP	O
patient	patient	NN	B-NP	O
is	be	VBZ	B-VP	O
doing	do	VBG	I-VP	O
well	well	RB	B-ADVP	O
on	on	IN	B-PP	O
current	current	JJ	B-NP	O
maintenance	maintenance	NN	I-NP	O
diuretic	diuretic	JJ	I-NP	O
schedule	schedule	NN	I-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
torsemide	torsemide	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
and	and	CC	I-NP	O
spironolactone	spironolactone	NN	I-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

Discharged	Discharge	VBN	B-VP	O
to	to	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
1-6275617	1-6275617	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Noe	Noe	NNP	B-NP	O
W.	W.	NNP	I-NP	O
Mcgoldrick	Mcgoldrick	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Ton	Ton	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Keneth	Keneth	NNP	B-NP	O
Bartuska	Bartuska	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
NUTRISOCHI	NUTRISOCHI	NNP	I-NP	O
ZIE-BRI	ZIE-BRI	NNP	I-NP	O
MEMORIAL	MEMORIAL	NNP	I-NP	O
Jose	Jose	NNP	I-NP	O
Mi	Mi	NNP	I-NP	O
Ant	Ant	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
DOULANI	DOULANI	NNP	B-NP	O
,	,	,	O	O
DEVIN	DEVIN	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LEEDER	LEEDER	NNP	B-NP	O
,	,	,	O	O
BRENDON	BRENDON	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
6215658	6215658	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
6/16/06	6/16/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
6/16/06	6/16/06	CD	B-NP	O

